Related Experiment Video
Updated: Feb 9, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
Published on: November 29, 2013
Cardiometabolic Risk Factors at 5 Years After Omega-3 Fatty Acid Supplementation in Infancy
Valene H L See1, Trevor A Mori2, Susan L Prescott3,4
1Medical School, Royal Perth Hospital, Perth, Australia; valene.see@uwa.edu.au.
Insights
Omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation in infancy reduced waist circumference in children. Boys supplemented with n-3 LCPUFA showed improved insulin levels and insulin resistance at age five.
Area of Science:
- Pediatrics
- Nutrition Science
- Cardiovascular Health
Background:
- Omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) may reduce adult cardiovascular risk.
- Animal studies suggest a link between infant n-3 LCPUFA and cardiovascular health.
- This study investigated the impact of infant n-3 LCPUFA supplementation on cardiometabolic risk factors.
Purpose of the Study:
- To assess the effect of n-3 LCPUFA supplementation in infancy on growth.
- To evaluate the impact on body composition at 5 years of age.
- To determine the influence on cardiometabolic risk factors at 5 years of age.
Main Methods:
- Randomized controlled trial with 420 infants from birth to 6 months.
- Supplementation with n-3 LCPUFA or olive oil (control).
- Measurements at birth and 5 years included anthropometry, blood pressure, heart rate, and biochemical markers.
Main Results:
- n-3 LCPUFA supplementation resulted in a smaller waist circumference at 5 years.
- Boys receiving n-3 LCPUFA showed reduced insulin concentrations (21%) and insulin resistance (22%).
- No significant differences in other growth and cardiometabolic factors were observed for the whole cohort.
Conclusions:
- Infant n-3 LCPUFA supplementation reduced waist circumference at 5 years.
- Boys showed improved insulin sensitivity, potentially benefiting long-term health.
- Effects were not observed in girls, and longer follow-up is needed.
Background:
Omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation during infancy may reduce adult cardiovascular risk as observed in animals. We assessed the effect of n-3 LCPUFA supplementation in infancy on growth, body composition, and cardiometabolic risk factors at 5 years of age.
Methods:
Infants were randomly assigned to a daily supplement of n-3 LCPUFA or olive oil (control) from birth to 6 months (n = 420). Measurements included weight, length, cord blood adipokines at birth and anthropometry, skinfolds, blood pressure, heart rate, fasting blood adipokines, and biochemistry at 5 years.
Results:
The infants who received n-3 LCPUFA had a smaller waist circumference at 5 years (coefficient: 1.1 cm; 95% confidence interval [CI]: 0.01 to 2.14), which remained significant after adjustments for confounders (coefficient: 0.8 cm; 95% CI: 0.19 to 1.30). Five-year-old boys who received n-3 LCPUFA supplementation as infants had a 21% reduction in insulin concentrations (ratio: 0.79; 95% CI: 0.66 to 0.94) and a 22% reduction in insulin resistance (ratio: 0.78; 95% CI: 0.64 to 0.95) compared with the control group. There were no other differences in growth and cardiometabolic risk factors between the groups for the whole cohort at birth, 2.5, or 5 years.
Conclusions:
Supplementation with n-3 LCPUFA in infancy revealed a reduction in waist circumference at 5 years. Boys in the n-3 LCPUFA group showed reduced insulin concentrations and insulin resistance at 5 years, which may have beneficial outcomes for later health. No effects were seen in girls. Longer term follow-up of the cohort is warranted to determine whether these differences are maintained into adolescence.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Socioemotional Development during Infancy
Primary Temperament Types
Factors Affecting Solubility
Structure of Lipids

